Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0009505,
umls-concept:C0017349,
umls-concept:C0018591,
umls-concept:C0024518,
umls-concept:C0208973,
umls-concept:C0332197,
umls-concept:C0332307,
umls-concept:C0442821,
umls-concept:C0678226,
umls-concept:C1412938,
umls-concept:C1511978,
umls-concept:C1517892,
umls-concept:C1704666,
umls-concept:C1880022,
umls-concept:C2347858
|
pubmed:issue |
10
|
pubmed:dateCreated |
1993-12-10
|
pubmed:abstractText |
Fourteen individuals with complete C2 deficiency from 11 families and 3 heterozygous C2-deficient individuals from two families were investigated. In all the 24 independent C2-deficient haplotypes, the complotype S042 was present and the majority (21/24) was [HLA-B18,S042,DR2]. All carried the type I C2 deficiency C2 pseudogene with its characteristic 28 bp deletion. All but two haplotypes had 10 AC/GT repeats in the TNF alpha microsatellite polymorphism and all but one of the haplotypes were identical at or near HLA-B as assessed by RFLP using BstEII digestion and two genomic probes, R5A and M20A, located 100 and 38 kb centromeric to HLA-B, respectively. The exceptional haplotype was HLA-B40 with four AC/GT repeats at TNF-alpha. Three of the haplotypes were not DR2 based on generic and sequence-specific oligonucleotide typing. Another four haplotypes showed different DO-variants detected by RFLP analysis using BglIIand Mspl digestion. Thus, the [HLA-B18,S042,DR2] haplotype appears to be more fixed in the region between the complement genes and the HLA-B locus (96%) than in the region between the complement genes and DR (88%) and DO loci (71%). Of the 14 individuals studied, six had SLE or SLE-like syndromes and six had a history of severe infections although two were apparently healthy. Three of the six SLE patients and two individuals with repeated infections were homozygous for [HLA-B18,S042,DR2] and also homozygous for DQB1*0602 and the common DO variant. Thus, MHC class II genes linked to the C2 pseudogene do not appear to determine different clinical consequences of C2 deficiency.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Complement C2,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQ Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQ beta-Chains,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQB1 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DR Antigens
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
151
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5856-63
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7901282-Base Sequence,
pubmed-meshheading:7901282-Complement C2,
pubmed-meshheading:7901282-Gene Deletion,
pubmed-meshheading:7901282-Genes, MHC Class II,
pubmed-meshheading:7901282-Genetic Linkage,
pubmed-meshheading:7901282-HLA-B Antigens,
pubmed-meshheading:7901282-HLA-DQ Antigens,
pubmed-meshheading:7901282-HLA-DQ beta-Chains,
pubmed-meshheading:7901282-HLA-DR Antigens,
pubmed-meshheading:7901282-Haplotypes,
pubmed-meshheading:7901282-Humans,
pubmed-meshheading:7901282-Molecular Sequence Data,
pubmed-meshheading:7901282-Polymorphism, Restriction Fragment Length
|
pubmed:year |
1993
|
pubmed:articleTitle |
Characterization of type I complement C2 deficiency MHC haplotypes. Strong conservation of the complotype/HLA-B-region and absence of disease association due to linked class II genes.
|
pubmed:affiliation |
Department of Medical Microbiology, Lund University, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|